Observational study on the use of remifentanil in general anesthesia. Drug utilisation research;Studio osservazionale sull'utilizzo di remifentanil in anestesia generale: Drug utilization research

Minerva Anestesiologica

Volumn 70, Issue 7-8, 2004, Pages 605-616

  Mastronardi, P ^a,c   Dellacasa, P ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE   (Italy)

Author keywords

Drug utilisation research; Pain post operative, therapy; Remifentanil

Indexed keywords

ATRACURIUM; ATROPINE; BENZYLISOQUINOLINE DERIVATIVE; CISATRACURIUM; DIAZEPAM; DROPERIDOL; FENTANYL; HALOTHANE; ISOFLURANE; KETOROLAC; MIDAZOLAM; MIVACURIUM; MORPHINE; NITROGEN OXIDE; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; PANCURONIUM; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; TRAMADOL; VECURONIUM;

ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ANESTHESIST; ANESTHETIC RECOVERY; AROUSAL; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG INFUSION; DRUG POTENCY; DRUG POTENTIATION; DRUG USE; DRUG UTILIZATION; GENERAL ANESTHESIA; HUMAN; ITALY; MAJOR CLINICAL STUDY; OPERATION DURATION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PUMP; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, GENERAL; ANESTHETICS, INTRAVENOUS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; ITALY; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE; PIPERIDINES; PREANESTHETIC MEDICATION; PROPOFOL;

EID: 4544379900     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. James MK, Feldman PL, Schuster SV, Bilotta JM Brackeen MF, Leighton HJ. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991;259:712-8.
2. Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr, Muir KT. Pharmacokinetics of remifentanil (G187084B) and its major metabolite (G190291) in patients undergoing elective inpatient surgery. Anesthesiology 1993; 79:893-903.
3. Glass PS, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH et al. Preliminary pharmacokynetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (G187084B). Anesth Analg 1993;77: 1031-40.
4. Rosow C. Remifentanil: a unique opioid analgesic. Anesthesiology 1993;79:875-6.
5. Burkle H, Dunbar S, Van Aken H. Rernifentanil: a novel, short-acting, mu-opioid. Anesth Analg 1996;83: 646-51.
6. Patel SS, Spencer CM. Remifentanil. Drugs 1996;52: 417-27.
7. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997;80:24-33.
8. Scott JC, Stanski DR. Decrease fentanyl and alfentanil dose requirement with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987;240:159-66.
9. Joshi GP, Jamerson BD, Roizen MF, Fleisher L, Twersky RS, Warner DS et al. Is there a learning curve associated with the use of remifentanil? Anesth Analg 2000;91: 1049-55.